Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Risk Stratification for Intermediate- and High-Risk Patients

被引：3
|
作者：
Katz, A. [1 ]
Kang, J. [2 ]
机构：
[1] FROS Radiat Oncol & CyberKnife Ctr, Flushing, NY USA
[2] Cornell Univ, Coll Med, New York, NY 10021 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1251
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2608
引用
收藏
页码：E250 / E250
页数：1
相关论文
共 50 条
  • [21] The role of proton beam therapy for patients with intermediate- and high-risk prostate cancer.
    Arimura, Takeshi
    Kondo, Naoaki
    Matsukawa, Kyoko
    Wada, Kiyotaka
    Kitano, Ikumi
    Chuman, Ikuko
    Nagata, Ichiro
    Ogino, Takashi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [22] RADIATION WITH OR WITHOUT 6 MONTHS OF ANDROGEN SUPPRESSION THERAPY IN INTERMEDIATE- AND HIGH-RISK CLINICALLY LOCALIZED PROSTATE CANCER: A POSTRANDOMIZATION ANALYSIS BY RISK GROUP
    Nguyen, Paul L.
    Chen, Ming-Hui
    Beard, Clair J.
    Suh, W. Warren
    Renshaw, Andrew A.
    Loffredo, Marian
    McMahon, Elizabeth
    Kantoff, Philip W.
    D'Amico, Anthony V.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (04): : 1046 - 1052
  • [23] Hypofractionated Dose Painting Intensity Modulated Radiation Therapy for Intermediate- to High-Risk Localized Prostate Cancer: Treatment With 20 Fractions
    Chan, J.
    Rowntree, T.
    Brunt, J. N.
    Howard, L.
    Syndikus, I.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E239 - E239
  • [24] Clinical outcomes of whole pelvis radiotherapy and stereotactic body radiotherapy boost for intermediate- and high-risk prostate cancer
    Kim, Hun Jung
    Phak, Jeong Hoon
    Kim, Woo Chul
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (05) : E342 - E347
  • [25] Stereotactic Body Radiation Therapy for Low-Intermediate Risk Prostate Cancer
    Haas, J.
    Katz, A. E.
    Santoro, M.
    Ashley, R.
    Mucciolo, R.
    Kessaris, D.
    Andrews, J.
    Clancey, O.
    Sanchez, A.
    Witten, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S361 - S361
  • [26] Subcastrate Testosterone Nadir and Clinical Outcomes in Intermediate- or High-Risk Localized Prostate Cancer
    Bryant, Alex K.
    McKay, Rana R.
    Kader, A. Karim
    Parsons, J. Kellogg
    Einck, John P.
    Kane, Christopher J.
    Mundt, Arno J.
    Murphy, James D.
    Rose, Brent S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (05): : 1068 - 1076
  • [27] Stereotactic Body Radiation Therapy (SBRT) for Intermediate and High-Risk Prostate Cancer: Early Adoption in a Community Hospital Setting
    Guilday, S. P.
    Dziemianowicz, M.
    Ricco, A.
    Lanciano, R. M.
    Hanlon, A.
    Feng, J.
    Good, M.
    Lamond, J. P.
    Arrigo, S. A.
    Obayomi-Davies, O., Jr.
    Yang, J.
    Brady, L. W., Jr.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E113 - E114
  • [28] Recent Trends in the Use of Androgen Deprivation Therapy with External Beam Radiation Therapy for Patients with Intermediate- and High-Risk Prostate Cancer
    Yang, D. D.
    Orio, P. F., III
    Nguyen, P. L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E151 - E152
  • [29] Stereotactic body radiation therapy (SBRT) for high-risk prostate cancer: Where are we now?
    Gonzalez-Motta, Alejandro
    Roach, Mack, III
    [J]. PRACTICAL RADIATION ONCOLOGY, 2018, 8 (03) : 185 - 202
  • [30] Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
    Andrew W Ju
    Hongkun Wang
    Eric K Oermann
    Benjamin A Sherer
    Sunghae Uhm
    Viola J Chen
    Arjun V Pendharkar
    Heather N Hanscom
    Joy S Kim
    Siyuan Lei
    Simeng Suy
    John H Lynch
    Anatoly Dritschilo
    Sean P Collins
    [J]. Radiation Oncology, 8
12345